Gary Curhan

Featured in: Favicon

biomedcentral.com Favicon

jamanetwork.com Favicon

thelancet.com Favicon

alzheimersanddementia.com Favicon

onlinelibrary.wiley.com Favicon

alzres.biomedcentral.com

Articles

Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes

Jan 29, 2024 | jamanetwork.com | Julie M. Paik |Helen Tesfaye |Gary Curhan |Heidi Zakoul

Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes Key PointsQuestion What is the association between sodium-glucose cotransporter 2 inhibitors (SGLT2is) and risk of developing nephrolithiasis in patients with type 2 diabetes?

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →